• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Highly efficient genome editing of human hematopoietic stem cells via a nano-silicon-blade delivery approach.通过纳米硅刀片递送方法对人类造血干细胞进行高效基因组编辑。
Integr Biol (Camb). 2017 Jun 19;9(6):548-554. doi: 10.1039/c7ib00060j.
2
Gene knockout in highly purified mouse hematopoietic stem cells by CRISPR/Cas9 technology.利用CRISPR/Cas9技术对高度纯化的小鼠造血干细胞进行基因敲除。
J Immunol Methods. 2021 Aug;495:113070. doi: 10.1016/j.jim.2021.113070. Epub 2021 May 4.
3
The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.造血干细胞基因编辑不断变化的格局:迈向Cas9临床转化的一步。
Curr Opin Hematol. 2017 Nov;24(6):481-488. doi: 10.1097/MOH.0000000000000385.
4
CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo.CRISPR/Cas9介导的人类造血干细胞/祖细胞中CCR5基因敲除在体内赋予对HIV-1的抗性
Mol Ther. 2017 Aug 2;25(8):1782-1789. doi: 10.1016/j.ymthe.2017.04.027. Epub 2017 May 17.
5
Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells.探索非病毒方法将 CRISPR-Cas 核糖核蛋白递送至造血干细胞。
Stem Cell Res Ther. 2024 Jul 29;15(1):233. doi: 10.1186/s13287-024-03848-4.
6
A Versatile Tool for the Quantification of CRISPR/Cas9-Induced Genome Editing Events in Human Hematopoietic Cell Lines and Hematopoietic Stem/Progenitor Cells.一种用于定量分析人类造血细胞系和造血干/祖细胞中 CRISPR/Cas9 诱导基因组编辑事件的多功能工具。
J Mol Biol. 2019 Jan 4;431(1):102-110. doi: 10.1016/j.jmb.2018.05.005. Epub 2018 May 9.
7
CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation.通过膜变形将CRISPR-Cas9递送至难以转染的细胞。
Sci Adv. 2015 Aug 14;1(7):e1500454. doi: 10.1126/sciadv.1500454. eCollection 2015 Aug.
8
Technical considerations for the use of CRISPR/Cas9 in hematology research.CRISPR/Cas9在血液学研究中应用的技术考量
Exp Hematol. 2017 Oct;54:4-11. doi: 10.1016/j.exphem.2017.07.006. Epub 2017 Jul 27.
9
Single-cell resolution reveals RalA GTPase expanding hematopoietic stem cells and facilitating of BCR-ABL1-driven leukemogenesis in a CRISPR/Cas9 gene editing mouse model.单细胞分辨率揭示了 RalA GTPase 扩增造血干细胞,并在 CRISPR/Cas9 基因编辑小鼠模型中促进 BCR-ABL1 驱动的白血病发生。
Int J Biol Sci. 2023 Feb 13;19(4):1211-1227. doi: 10.7150/ijbs.76993. eCollection 2023.
10
CRISPR Base Editing in Induced Pluripotent Stem Cells.诱导多能干细胞中的CRISPR碱基编辑
Methods Mol Biol. 2019;2045:337-346. doi: 10.1007/7651_2019_243.

引用本文的文献

1
Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells.探索非病毒方法将 CRISPR-Cas 核糖核蛋白递送至造血干细胞。
Stem Cell Res Ther. 2024 Jul 29;15(1):233. doi: 10.1186/s13287-024-03848-4.
2
Current Strategies for Increasing Knock-In Efficiency in CRISPR/Cas9-Based Approaches.基于CRISPR/Cas9方法提高敲入效率的当前策略
Int J Mol Sci. 2024 Feb 20;25(5):2456. doi: 10.3390/ijms25052456.
3
Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells.CRISPR/Cas9 递送方法在干细胞治疗性基因编辑中的最新进展。
Stem Cell Rev Rep. 2023 Nov;19(8):2576-2596. doi: 10.1007/s12015-023-10585-3. Epub 2023 Sep 18.
4
Fluorinated Silane-Modified Filtroporation Devices Enable Gene Knockout in Human Hematopoietic Stem and Progenitor Cells.氟化硅烷修饰的滤过转染装置可实现人造血干/祖细胞的基因敲除。
ACS Appl Mater Interfaces. 2023 Sep 6;15(35):41299-41309. doi: 10.1021/acsami.3c07045. Epub 2023 Aug 24.
5
CRISPR medicine for blood disorders: Progress and challenges in delivery.用于血液疾病的CRISPR疗法:递送方面的进展与挑战
Front Genome Ed. 2023 Jan 6;4:1037290. doi: 10.3389/fgeed.2022.1037290. eCollection 2022.
6
Microfluidic and Nanofluidic Intracellular Delivery.微流控和纳流控细胞内递药。
Adv Sci (Weinh). 2021 Aug;8(15):e2004595. doi: 10.1002/advs.202004595. Epub 2021 Jun 6.
7
Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.用于 CRISPR/Cas9 基因组编辑的 Cas9 核糖核蛋白递送策略。
Theranostics. 2021 Jan 1;11(2):614-648. doi: 10.7150/thno.47007. eCollection 2021.
8
Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing.用于CRISPR/Cas基因组编辑的纳米囊泡介导递送系统
Pharmaceutics. 2020 Dec 18;12(12):1233. doi: 10.3390/pharmaceutics12121233.
9
Lipid-Bicelle-Coated Microfluidics for Intracellular Delivery with Reduced Fouling.脂质双立方膜包覆的微流控芯片用于细胞内递送,可减少污染。
ACS Appl Mater Interfaces. 2020 Oct 14;12(41):45744-45752. doi: 10.1021/acsami.0c11485. Epub 2020 Oct 1.
10
A review of emerging physical transfection methods for CRISPR/Cas9-mediated gene editing.CRISPR/Cas9 介导的基因编辑新兴物理转染方法综述。
Theranostics. 2020 Apr 15;10(12):5532-5549. doi: 10.7150/thno.43465. eCollection 2020.

本文引用的文献

1
Cas9 Ribonucleoprotein Delivery via Microfluidic Cell-Deformation Chip for Human T-Cell Genome Editing and Immunotherapy.通过微流控细胞变形芯片递送Cas9核糖核蛋白用于人类T细胞基因组编辑和免疫治疗
Adv Biosyst. 2017 Feb;1(1-2):e1600007. doi: 10.1002/adbi.201600007. Epub 2017 Jan 16.
2
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.利用CRISPR/Cas9对小鼠和人类造血祖细胞进行高效基因组编辑
Cell Rep. 2016 Oct 25;17(5):1453-1461. doi: 10.1016/j.celrep.2016.09.092.
3
Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles.使用可生物还原脂质纳米颗粒高效递送基因组编辑蛋白。
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):2868-73. doi: 10.1073/pnas.1520244113. Epub 2016 Feb 29.
4
CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation.通过膜变形将CRISPR-Cas9递送至难以转染的细胞。
Sci Adv. 2015 Aug 14;1(7):e1500454. doi: 10.1126/sciadv.1500454. eCollection 2015 Aug.
5
Gating of a mechanosensitive channel due to cellular flows.由于细胞流动导致机械敏感通道的门控。
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9822-7. doi: 10.1073/pnas.1512152112. Epub 2015 Jul 27.
6
Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy.用于人类基因治疗的CRISPR-Cas9基因组编辑技术的递送与特异性
Hum Gene Ther. 2015 Jul;26(7):443-51. doi: 10.1089/hum.2015.074.
7
Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection.通过Cas9蛋白转染实现快速高效的哺乳动物细胞工程。
J Biotechnol. 2015 Aug 20;208:44-53. doi: 10.1016/j.jbiotec.2015.04.024. Epub 2015 May 21.
8
An engineered membrane to measure electroporation: effect of tethers and bioelectronic interface.一种用于测量电穿孔的工程膜:系链和生物电子界面的影响。
Biophys J. 2014 Sep 16;107(6):1339-51. doi: 10.1016/j.bpj.2014.07.056.
9
Targeted genome editing in human repopulating haematopoietic stem cells.人类重编程造血干细胞中的靶向基因组编辑。
Nature. 2014 Jun 12;510(7504):235-240. doi: 10.1038/nature13420. Epub 2014 May 28.
10
Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis.利用脑膜炎奈瑟菌 Cas9 高效进行人类多能干细胞的基因组编辑。
Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15644-9. doi: 10.1073/pnas.1313587110. Epub 2013 Aug 12.

通过纳米硅刀片递送方法对人类造血干细胞进行高效基因组编辑。

Highly efficient genome editing of human hematopoietic stem cells via a nano-silicon-blade delivery approach.

作者信息

Ma Yuan, Han Xin, Quintana Bustamante Oscar, Bessa de Castro Ricardo, Zhang Kai, Zhang Pengchao, Li Ying, Liu Zongbin, Liu Xuewu, Ferrari Mauro, Hu Zhongbo, Carlos Segovia José, Qin Lidong

机构信息

College of Materials Sciences and Optoelectronics, University of Chinese Academy of Sciences, Beijing, 100049, China.

出版信息

Integr Biol (Camb). 2017 Jun 19;9(6):548-554. doi: 10.1039/c7ib00060j.

DOI:10.1039/c7ib00060j
PMID:28513735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5598083/
Abstract

Recently, the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 bacterial immunity system has opened a promising avenue to treat genetic diseases that affect the human hematopoietic stem cells (HSCs). Therefore, finding a highly efficient delivery method capable of modifying the genome in the hard-to-transfect HSCs, combined with the advanced CRISPR-Cas9 system, may meet the challenges for dissecting the hematologic disease mechanisms and facilitate future clinical applications. Here, we developed an effective HSC-specified delivery microfluidic chip to disrupt the cell membrane transiently by inducing rapid mechanical deformation that allowed the delivery of biomaterials into the cytoplasm from the surrounding matrix. Compared with the previous designs, the new nano-silicon-blade structure was specifically optimized for HSCs. Using the silicon substrate, the sharpness and rigidity of the nano-blade constriction was largely enhanced to improve the biomaterials delivery efficiency. We achieved highly efficient delivery results by transporting various macro-molecules into the HSCs. Moreover, the treated HSCs possess high viability and maintain inherent pluripotency after the delivery via the Nano-Blade Chip (NB-Chip). Subsequently, we disrupted the p42 isoform in C/EBPα on the NB-Chip and induced HSCs into a myeloid proliferation behavior. In conclusion, the NB-Chip provides a harmless, rapid and high-throughput gene editing approach for the HSC study and therapeutics.

摘要

最近,成簇规律间隔短回文重复序列(CRISPR)-Cas9细菌免疫系统为治疗影响人类造血干细胞(HSC)的遗传疾病开辟了一条充满希望的途径。因此,找到一种能够在难以转染的造血干细胞中高效修饰基因组的递送方法,并结合先进的CRISPR-Cas9系统,可能会应对剖析血液疾病机制的挑战,并推动未来的临床应用。在此,我们开发了一种有效的造血干细胞特异性递送微流控芯片,通过诱导快速机械变形来瞬时破坏细胞膜,从而使生物材料能够从周围基质进入细胞质。与先前的设计相比,新的纳米硅刀片结构是专门针对造血干细胞进行优化的。利用硅基板,纳米刀片收缩处的锋利度和刚度大大提高,从而提高了生物材料的递送效率。我们通过将各种大分子输送到造血干细胞中,获得了高效的递送结果。此外,经处理的造血干细胞具有高活力,并且在通过纳米刀片芯片(NB芯片)递送后仍保持固有的多能性。随后,我们在NB芯片上破坏了C/EBPα中的p42亚型,并诱导造血干细胞出现髓系增殖行为。总之,NB芯片为造血干细胞研究和治疗提供了一种无害、快速且高通量的基因编辑方法。